Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omega Fund VI
Boston, MA, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Omega Funds is a leading international investment firm that creates and invests in life sciences companies targeting urgent medical needs. Founded in 2004, the firm has raised over $2 billion to support innovation across the healthcare industry, including its $438 million Omega Fund VI. The firm employs a flexible investment strategy, participating in seed rounds, clinical-stage growth capital, and secondary market transactions. Omega Funds focuses on diverse therapeutic areas, including oncology, immunology, and rare diseases. With offices in Boston and Geneva, the firm leverages a global network to identify and scale transformative biotech ventures.
- Therapeutic areas
- ImmunologyCardiovascularNeurologyRare DiseasesOncology
- Modalities
- Small moleculeMonoclonal antibodyCell therapyGene therapymRNA-based drugs
- Industry
- Investors
Beyond the preview
Go deeper on Omega Fund VI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omega Fund VI.